Cefazolin: Difference between revisions
Ostermayer (talk | contribs) No edit summary |
Ostermayer (talk | contribs) No edit summary Tag: Reverted |
||
| Line 1: | Line 1: | ||
==General== | == General == | ||
*Type: [[Is Generation::1st generation]] [[Is DrugClass::Cephalosporin]] | * '''Type:''' [[Is Generation::1st generation]] [[Is DrugClass::Cephalosporin]] | ||
*Dosage Forms: | * '''Dosage Forms:''' Intramammary suspension, Ophthalmic ointment | ||
* '''Routes of Administration:''' Intramammary (IMM), Topical (Ophthalmic) | |||
*Routes of Administration: | * '''Common Trade Names:''' Cepravin | ||
*Common Trade Names: | * '''Note:''' Cefalonium is a semi-synthetic cephalosporin used almost exclusively in **veterinary medicine**. It is widely used for "Dry Cow" therapy to treat and prevent mastitis. It is not approved for human use in most jurisdictions. | ||
==Adult Dosing== | == Adult Dosing == | ||
===General=== | === General === | ||
* | * '''Human Systemic Dosing:''' Not established. Not indicated for human use. | ||
* | * '''Veterinary (Bovine) - Dry Cow Therapy:''' | ||
* | ** Infuse one syringe (250 mg) into the teat canal of each quarter immediately after the last milking of the lactation. | ||
* | ** Massage udder upwards to distribute the suspension. | ||
=== | === Ophthalmic (Veterinary) === | ||
* | * Apply a small amount (~1 cm) of ointment to the conjunctival sac q8–12h or as directed for infectious keratoconjunctivitis. | ||
== | == Pediatric Dosing == | ||
* | * '''Safety and Efficacy:''' Not applicable (Veterinary drug). | ||
== | == Special Populations == | ||
* | * '''Pregnancy/Lactation (Humans):''' No data available. | ||
* '''Veterinary Lactation (Withdrawal Periods):''' | |||
** Milk Withdrawal: Milk from treated cows must not be used for human consumption for a specific period post-calving (often 96 hours post-calving if the dry period was of sufficient length). | |||
** Meat Withdrawal: Animals must not be slaughtered for human consumption during treatment or for a specified period (e.g., 21 days) after the last treatment. | |||
== | == Contraindications == | ||
* Known hypersensitivity to Cephalosporins. | |||
* History of anaphylaxis to Penicillins (Risk of cross-reactivity). | |||
* | * '''Veterinary:''' Do not use in lactating cows; intended for use during the dry period only. | ||
=== | == Adverse Reactions == | ||
* | === Serious === | ||
* | * Anaphylactic reactions (rare in animals). | ||
* Superinfection (fungal or resistant bacterial growth). | |||
=== | === Common === | ||
* | * Local irritation at the infusion site. | ||
* | * Transient eye irritation (ophthalmic use). | ||
=== | == Pharmacology == | ||
* | * '''Mechanism of Action:''' Bactericidal; inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), causing defects in the cell wall and leading to cell lysis. | ||
* | * '''Absorption:''' | ||
* | ** ''Intramammary:'' Formulated for slow release to persist in the udder for prolonged periods (weeks) during the dry period. Systemic absorption is minimal. | ||
** ''Ophthalmic:'' Penetrates the cornea efficiently. | |||
* '''Chemical Class:''' Synthetic organic compound; contains Isonicotinamides, Thiophenes, and Pyridinium structures. | |||
== | == Antibiotic Sensitivities == | ||
* | * ''Note: As a 1st Generation Cephalosporin, the spectrum is primarily Gram-positive with modest Gram-negative coverage.'' | ||
{| class="wikitable" | {| class="wikitable" | ||
! Group !! Organism !! Sensitivity | |||
|- | |- | ||
| || | | rowspan="8" | '''Gram Positive''' | ||
| Streptococcus agalactiae || '''S''' | |||
|- | |- | ||
| || | | Streptococcus dysgalactiae || '''S''' | ||
|- | |- | ||
| || | | Streptococcus uberis || '''S''' | ||
|- | |- | ||
| || | | Streptococcus pyogenes || '''S''' | ||
|- | |- | ||
| | | Enterococcus spp. || R | ||
|- | |- | ||
| || | | Staphylococcus aureus (MSSA) || '''S''' | ||
|- | |- | ||
| || | | MRSA || R | ||
|- | |- | ||
| || | | Corynebacterium pyogenes || '''S''' | ||
|- | |- | ||
| || | | rowspan="8" | '''Gram Negatives''' | ||
| Escherichia coli || '''S'''/I | |||
|- | |- | ||
| | | Klebsiella spp. || '''S''' | ||
|- | |- | ||
| | | Proteus mirabilis || '''S''' | ||
|- | |- | ||
| | | Enterobacter spp. || R | ||
|- | |- | ||
| | | Pseudomonas aeruginosa || R | ||
|- | |- | ||
| || | | Pasteurella multocida || '''S''' | ||
|- | |- | ||
| || | | Fusobacterium necrophorum || '''S''' | ||
|- | |- | ||
| | | Haemophilus influenzae || R | ||
|} | |} | ||
'''Key:''' '''S''' = Susceptible, '''I''' = Intermediate, '''R''' = Resistant. | |||
== | == References == | ||
* [https://guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=13609 IUPHAR/BPS Guide to PHARMACOLOGY: Cefalonium] | |||
* [https://en.wikipedia.org/wiki/Cefalonium Wikipedia: Cefalonium] | |||
* [https://fpnotebook.com/ID/Pharm/FrstGnrtnCphlsprn.htm FP Notebook: First Generation Cephalosporins] | |||
*[ | |||
[[Category:Pharmacology]] [[Category:ID]] | [[Category:Pharmacology]] | ||
[[Category:ID]] | |||
Revision as of 17:16, 27 January 2026
General
- Type: 1st generation Cephalosporin
- Dosage Forms: Intramammary suspension, Ophthalmic ointment
- Routes of Administration: Intramammary (IMM), Topical (Ophthalmic)
- Common Trade Names: Cepravin
- Note: Cefalonium is a semi-synthetic cephalosporin used almost exclusively in **veterinary medicine**. It is widely used for "Dry Cow" therapy to treat and prevent mastitis. It is not approved for human use in most jurisdictions.
Adult Dosing
General
- Human Systemic Dosing: Not established. Not indicated for human use.
- Veterinary (Bovine) - Dry Cow Therapy:
- Infuse one syringe (250 mg) into the teat canal of each quarter immediately after the last milking of the lactation.
- Massage udder upwards to distribute the suspension.
Ophthalmic (Veterinary)
- Apply a small amount (~1 cm) of ointment to the conjunctival sac q8–12h or as directed for infectious keratoconjunctivitis.
Pediatric Dosing
- Safety and Efficacy: Not applicable (Veterinary drug).
Special Populations
- Pregnancy/Lactation (Humans): No data available.
- Veterinary Lactation (Withdrawal Periods):
- Milk Withdrawal: Milk from treated cows must not be used for human consumption for a specific period post-calving (often 96 hours post-calving if the dry period was of sufficient length).
- Meat Withdrawal: Animals must not be slaughtered for human consumption during treatment or for a specified period (e.g., 21 days) after the last treatment.
Contraindications
- Known hypersensitivity to Cephalosporins.
- History of anaphylaxis to Penicillins (Risk of cross-reactivity).
- Veterinary: Do not use in lactating cows; intended for use during the dry period only.
Adverse Reactions
Serious
- Anaphylactic reactions (rare in animals).
- Superinfection (fungal or resistant bacterial growth).
Common
- Local irritation at the infusion site.
- Transient eye irritation (ophthalmic use).
Pharmacology
- Mechanism of Action: Bactericidal; inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), causing defects in the cell wall and leading to cell lysis.
- Absorption:
- Intramammary: Formulated for slow release to persist in the udder for prolonged periods (weeks) during the dry period. Systemic absorption is minimal.
- Ophthalmic: Penetrates the cornea efficiently.
- Chemical Class: Synthetic organic compound; contains Isonicotinamides, Thiophenes, and Pyridinium structures.
Antibiotic Sensitivities
- Note: As a 1st Generation Cephalosporin, the spectrum is primarily Gram-positive with modest Gram-negative coverage.
| Group | Organism | Sensitivity |
|---|---|---|
| Gram Positive | Streptococcus agalactiae | S |
| Streptococcus dysgalactiae | S | |
| Streptococcus uberis | S | |
| Streptococcus pyogenes | S | |
| Enterococcus spp. | R | |
| Staphylococcus aureus (MSSA) | S | |
| MRSA | R | |
| Corynebacterium pyogenes | S | |
| Gram Negatives | Escherichia coli | S/I |
| Klebsiella spp. | S | |
| Proteus mirabilis | S | |
| Enterobacter spp. | R | |
| Pseudomonas aeruginosa | R | |
| Pasteurella multocida | S | |
| Fusobacterium necrophorum | S | |
| Haemophilus influenzae | R |
Key: S = Susceptible, I = Intermediate, R = Resistant.
